European Committee For Treatment And Research In Multiple Sclerosis Research Articles

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) - 31st Congress. Barcelona, Spain - October 7-10, 2015

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) - 31st Congress. Barcelona, Spain - October 7-10, 2015

29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark - October 2-5, 2013

29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark - October 2-5, 2013

29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark - October 2-5, 2013

29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark - October 2-5, 2013

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Lyon, France - October 10-13, 2012

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Lyon, France - October 10-13, 2012

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Lyon, France - October 10-13, 2012

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Lyon, France - October 10-13, 2012

Joint 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Conference of Rehabilitation in Multiple Sclerosis (RIMS): An update on clinical findings to improve outcomes in multiple sclerosis

Joint 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Conference of Rehabilitation in Multiple Sclerosis (RIMS): An update on clinical findings to improve outcomes in multiple sclerosis

Joint 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Conference of Rehabilitation in Multiple Sclerosis (RIMS): An update on clinical findings to improve outcomes in multiple sclerosis

Joint 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Conference of Rehabilitation in Multiple Sclerosis (RIMS): An update on clinical findings to improve outcomes in multiple sclerosis

Revisión de las novedades presentadas en el XXVI Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (I)

The most significant data presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in France in October 2012, have been summarised in the fifth edition of the Post-ECTRIMS Experts Meeting, held in Madrid in October 2012. This led to the drafting of this review, which has been published in three parts. This third part of the Post-ECTRIMS review presents the findings from the latest studies conducted with disease-modifying treatments, more specifically with glatiramer acetate, laquinimod, ponesimod, BG-12, teriflunomide, daclizumab, natalizumab and secukinumab (AIN457). Likewise, we also address the reasons that justify the search for innovative treatments for multiple sclerosis, with antigen-specific therapy, cell therapy and therapy aimed at promoting remyelination being highlighted among other future therapeutic strategies. Access to new pharmacological agents and the complexity of the therapy of multiple sclerosis in the future will require new design strategies and directions in clinical trials, including the use of surrogate markers, new statistical applications, superiority, inferiority or equivalence clinical trials and adaptable designs. © 2013 Revista de Neurologia.

26th Congress of the European Committee for Treatment and Research in MS

AbstractThe 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held in Gothenberg, Sweden in October, attracting 6300 participants from around the world. Katherine Laight reports on some of the highlights of the Congress. Copyright © 2010 Wiley Interface Ltd

Highlights from the 25th Congress of the European Committee for treatment and research in multiple sclerosis (ECTRIMS)

The Rhine river was the scenario of this year's congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in the Dusseldorf Messe right beside the river in September 9-12, 2009. The meeting contained a number of important new contributions with a direct impact in how patients are and can be treated in the current clinical setting.

An overview of the clincial trial data report at the 22nd European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual congress, held this autumn in Madrid

Future PrescriberVolume 7, Issue 3 p. 25-27 Conference ReportFree Access An overview of the clincial trial data report at the 22nd European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual congress, held this autumn in Madrid First published: 08 August 2008 https://doi.org/10.1002/fps.28AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume7, Issue3July/September 2006Pages 25-27 RelatedInformation